3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company: Oruka Therapeutics, Inc.
Filed: July 1, 2025
Period of Report: July 1, 2025
Accession Number: 0001062993-25-012405

View Document ↗ View on SEC.gov ↗